• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    46.62 Up 0.37(0.80%) Feb 24, 4:00PM EST
    |After Hours : 46.62 0.00 (0.00%) Feb 24, 4:13PM EST
    Prev Close:46.25
    Open:45.90
    Bid:N/A
    Ask:N/A
    1y Target Est:62.73
    Beta:3.16165
    Earnings Date:May 1 - May 5 (Est.)
    Day's Range:45.00 - 47.15
    52wk Range:31.38 - 80.11
    Volume:642,690
    Avg Vol (3m):1,121,090
    Market Cap:4.00B
    P/E (ttm):N/A
    EPS (ttm):-4.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALNY

    Comparison

    Symbol% ChgMkt Cap
    ALNYUp 0.80%4.00B
    PFEUp 0.59%207.90B
    MRKUp 0.47%182.41B
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):84.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-5.09
    Quarterly EPS Est (Mar-17) :-1.28
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-0.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. Its pipeline of investigational RNAi therapeutics is focused on genetic medicines, cardio-metabolic d... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback